Repealing the requirement that each local correctional facility make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders; requiring the Maryland Secretary of Health to annually provide each county a grant equal to the costs incurred by the county for the implementation of a certain medication-assisted treatment program; and expanding the authorized uses of the Opioid Restitution Fund.
Bill File Type: Regular
Effective Date(s): October 1, 2024
HistoryToggle History Dropdown
File CodeToggle Filecode Dropdown
SubjectsToggle Subjects Dropdown
StatutesToggle Statutes Dropdown
Last Updated: 2/20/2024 12:01 PM